The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-cyanopropan-2-yl)-3-(5-(4-((tetrahydro-2H-pyran-4-ylamino)methyl)phenyl)isoxazol-3-yl)benzamide ID: ALA1683439
PubChem CID: 53326759
Max Phase: Preclinical
Molecular Formula: C26H28N4O3
Molecular Weight: 444.54
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C#N)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1
Standard InChI: InChI=1S/C26H28N4O3/c1-26(2,17-27)29-25(31)21-5-3-4-20(14-21)23-15-24(33-30-23)19-8-6-18(7-9-19)16-28-22-10-12-32-13-11-22/h3-9,14-15,22,28H,10-13,16H2,1-2H3,(H,29,31)
Standard InChI Key: WWJPXQHKUSHQQL-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
-2.4002 -16.4405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4185 -17.2623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7132 -17.6893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9895 -17.2914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9752 -16.4663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6810 -16.0431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2508 -16.0704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5465 -16.3025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0090 -15.6175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4950 -14.9710 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2749 -15.2512 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8329 -15.6244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2419 -16.3470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0690 -16.3539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4874 -15.6392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0770 -14.9199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2512 -14.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5000 -14.1993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3279 -14.2031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0878 -13.4885 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7419 -14.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1406 -17.6589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8450 -17.2318 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.5671 -17.6283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2680 -17.1999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.9879 -17.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0119 -18.4171 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.3056 -18.8463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5794 -18.4516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5667 -14.9150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9406 -15.1252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7362 -15.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3898 -14.9108 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17 12 1 0
16 18 1 0
4 5 1 0
18 19 1 0
2 3 1 0
18 20 2 0
8 9 1 0
19 21 1 0
9 10 2 0
2 22 1 0
10 11 1 0
22 23 1 0
11 7 1 0
23 24 1 0
24 25 1 0
5 6 2 0
9 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
24 29 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
13 14 1 0
5 7 1 0
14 15 2 0
7 8 2 0
21 30 1 0
15 16 1 0
21 31 1 0
3 4 2 0
21 32 1 0
16 17 2 0
30 33 3 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 444.54Molecular Weight (Monoisotopic): 444.2161AlogP: 4.31#Rotatable Bonds: 7Polar Surface Area: 100.18Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.34CX LogP: 3.07CX LogD: 1.14Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -1.24
References 1. Gamber GG, Meredith E, Zhu Q, Yan W, Rao C, Capparelli M, Burgis R, Enyedy I, Zhang JH, Soldermann N, Beattie K, Rozhitskaya O, Koch KA, Pagratis N, Hosagrahara V, Vega RB, McKinsey TA, Monovich L.. (2011) 3,5-diarylazoles as novel and selective inhibitors of protein kinase D., 21 (5): [PMID:21300545 ] [10.1016/j.bmcl.2011.01.014 ]